Jonathan Zinman is listed as a director on 1 SEC Form D filing by 1 issuer in Nov 2025: Par Health, Inc. (St. Louis, MO — pharmaceuticals — 2025; $763M reported sold to 234 investors).
What this means One deal on file with the SEC, filed Nov 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrew Gonce (1 shared filing), Jack Boyle (1 shared filing), Jake Longenecker (1 shared filing), Jeffrey Wiegers (1 shared filing), Joshua Murray (1 shared filing) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jonathan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 7 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Jonathan Zinman and found 2 differences, 1 worth asking the sponsor about: Bankruptcy case: Jonathan D. F. Zinman; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.